Terms: = Breast cancer AND BRCA2, FAD, 675, ENSG00000139618, FACD, FAD1, FANCD, FANCD1, BRCC2, RP11-298P3_4 AND Treatment
31538 results:
1. Design and Evaluation of NSAID Derivatives as AKR1C3 Inhibitors for breast cancer treatment through Computer-Aided Drug Design and In Vitro Analysis.
Fonseca-Benítez V; Acosta-Guzmán P; Sánchez JE; Alarcón Z; Jiménez RA; Guevara-Pulido J
Molecules; 2024 Apr; 29(8):. PubMed ID: 38675620
[TBL] [Abstract] [Full Text] [Related]
2. Crosstalk of disulfidptosis-related subtypes identifying a prognostic signature to improve prognosis and immunotherapy responses of clear cell renal cell carcinoma patients.
Ren L; Liu J; Lin Q; He T; Huang G; Wang W; Zhan X; He Y; Huang B; Mao X
BMC Genomics; 2024 Apr; 25(1):413. PubMed ID: 38671348
[TBL] [Abstract] [Full Text] [Related]
3. Hyaluronic acid-based injectable formulation developed to mitigate metastasis and radiation-induced skin fibrosis in breast cancer treatment.
Wang YC; Shueng PW; Hu CY; Tung FI; Chen MH; Liu TY
Carbohydr Polym; 2024 Jul; 336():122136. PubMed ID: 38670762
[TBL] [Abstract] [Full Text] [Related]
4. Women's Knowledge of Genomic Testing and Precision Medicine in breast cancer treatment Decision-Making.
Robles-Rodriguez E; Houser L; Sanchez B; Ormerod C; Washburn S; Oertle SK; Jerome-D'Emilia B
Oncol Nurs Forum; 2024 Apr; 51(3):199-208. PubMed ID: 38668907
[TBL] [Abstract] [Full Text] [Related]
5. Evaluation of large language models in breast cancer clinical scenarios: a comparative analysis based on ChatGPT-3.5, ChatGPT-4.0, and Claude2.
Deng L; Wang T; Yangzhang ; Zhai Z; Tao W; Li J; Zhao Y; Luo S; Xu J
Int J Surg; 2024 Apr; 110(4):1941-1950. PubMed ID: 38668655
[TBL] [Abstract] [Full Text] [Related]
6. Real-World treatment Patterns and Clinical Outcomes among Patients Receiving CDK4/6 Inhibitors for Metastatic breast cancer in a Canadian Setting Using AI-Extracted Data.
Moulson R; Feugère G; Moreira-Lucas TS; Dequen F; Weiss J; Smith J; Brezden-Masley C
Curr Oncol; 2024 Apr; 31(4):2172-2184. PubMed ID: 38668064
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic Factors Associated with Tumor Recurrence and Overall Survival in Soft Tissue Sarcomas of the Extremities in a Colombian Reference cancer Center.
Díaz Casas SE; Villacrés JM; Lehmann Mosquera C; García Mora M; Mariño Lozano I; Ángel Aristizábal J; Suarez Rodríguez R; Duarte Torres CA; Sánchez Pedraza R
Curr Oncol; 2024 Mar; 31(4):1725-1738. PubMed ID: 38668034
[No Abstract] [Full Text] [Related]
8. Weight management personas of breast cancer patients undergoing chemotherapy in China: a multi-method study.
Li X; Zhang N; Yang J; Geng Z; Zhou J; Zhang J
BMC Med Inform Decis Mak; 2024 Apr; 24(1):108. PubMed ID: 38664653
[TBL] [Abstract] [Full Text] [Related]
9. Factors impacting quality of life for breast cancer survivors.
Davis SC; Snyder E
Nurse Pract; 2024 May; 49(5):17-23. PubMed ID: 38662491
[TBL] [Abstract] [Full Text] [Related]
10. Comparing symptom clusters in cancer survivors by cancer diagnosis: A latent class profile analysis.
Lee LJ; Han CJ; Saligan L; Wallen GR
Support Care Cancer; 2024 Apr; 32(5):308. PubMed ID: 38662054
[TBL] [Abstract] [Full Text] [Related]
11. The efficiency and safety of low-dose apatinib combined with oral vinorelbine in pretreated HER2-negative metastatic breast cancer.
Huang JY; Chen XL; Xie XF; Song L; Chen LP; Lan XF; Bai X; Chen X; Du CW
Cancer Med; 2024 Apr; 13(8):e7181. PubMed ID: 38659376
[TBL] [Abstract] [Full Text] [Related]
12. Are depression and poor sleep quality a major problem in Turkish Women receiving chemotherapy for breast cancer?
Buyuksimsek M; Gulmez A; Pirinci O; Tohumcuoglu M; Kidi MM
Rev Assoc Med Bras (1992); 2024; 70(3):e20231377. PubMed ID: 38656011
[TBL] [Abstract] [Full Text] [Related]
13. [Perceived work self-efficacy, and characteristics of return to work in women survivors of breast cancer at two reference centers in Colombia].
Vasquez Trespalacios EM; Oliveros-Riveros LM; Mercado González DC
Arch Prev Riesgos Labor; 2024 Apr; 27(2):140-156. PubMed ID: 38655594
[TBL] [Abstract] [Full Text] [Related]
14. Chemotherapy-elicited extracellular vesicle CXCL1 from dying cells promotes triple-negative breast cancer metastasis by activating TAM/PD-L1 signaling.
Wang S; Li J; Hong S; Wang N; Xu S; Yang B; Zheng Y; Zhang J; Pan B; Hu Y; Wang Z
J Exp Clin Cancer Res; 2024 Apr; 43(1):121. PubMed ID: 38654356
[TBL] [Abstract] [Full Text] [Related]
15. NSABP FB-10: a phase Ib/II trial evaluating ado-trastuzumab emtansine (T-DM1) with neratinib in women with metastatic HER2-positive breast cancer.
Jacobs SA; Wang Y; Abraham J; Feng H; Montero AJ; Lipchik C; Finnigan M; Jankowitz RC; Salkeni MA; Maley SK; Puhalla SL; Piette F; Quinn K; Chang K; Nagy RJ; Allegra CJ; Vehec K; Wolmark N; Lucas PC; Srinivasan A; Pogue-Geile KL
Breast Cancer Res; 2024 Apr; 26(1):69. PubMed ID: 38650031
[TBL] [Abstract] [Full Text] [Related]
16. Tumor microenvironment restricts IL-10 induced multipotent progenitors to myeloid-lymphatic phenotype.
Volk-Draper L; Athaiya S; Espinosa Gonzalez M; Bhattarai N; Wilber A; Ran S
PLoS One; 2024; 19(4):e0298465. PubMed ID: 38640116
[TBL] [Abstract] [Full Text] [Related]
17. Postpartum breast cancer and Survival in Women With Germline BRCA Pathogenic Variants.
Zhang Z; Ye S; Bernhardt SM; Nelson HD; Velie EM; Borges VF; Woodward ER; Evans DGR; Schedin PJ
JAMA Netw Open; 2024 Apr; 7(4):e247421. PubMed ID: 38639936
[TBL] [Abstract] [Full Text] [Related]
18. Radiation for inflammatory breast cancer: Updates.
Stauder MC
Int Rev Cell Mol Biol; 2024; 384():25-46. PubMed ID: 38637098
[TBL] [Abstract] [Full Text] [Related]
19. Inflammatory breast cancer (IBC) advocacy-Past, present and future!
Donahue J; Earls J; Fraser V; Mason G; Pirowski H; Stephens P
Int Rev Cell Mol Biol; 2024; 384():153-164. PubMed ID: 38637097
[TBL] [Abstract] [Full Text] [Related]
20. Methodology for Using Real-World Data From Electronic Health Records to Assess Chemotherapy Administration in Women With breast cancer.
Bhimani J; O'Connell K; Ergas IJ; Foley M; Gallagher GB; Griggs JJ; Heon N; Kolevska T; Kotsurovskyy Y; Kroenke CH; Laurent CA; Liu R; Nakata KG; Persaud S; Rivera DR; Roh JM; Tabatabai S; Valice E; Bowles EJA; Bandera EV; Kushi LH; Kantor ED
JCO Clin Cancer Inform; 2024 Apr; 8():e2300209. PubMed ID: 38635936
[TBL] [Abstract] [Full Text] [Related]
[Next]
